Two Good Manufacturing Practice (GMP) inspectors from the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia, visited Japan from September 14 to 16 to enhance their insight onGood Gene, Cellular, and Tissue-based Products Manufacturing Practice (GCTP) Compliance Inspection and joined the inspection conducted by the PMDA. This training was conducted in cooperation with NIPRO CORPORATION to help them learn PMDA inspection methods on regenerative medicine manufacturers. To make the training fruitful, a preliminary briefing by the Office of Manufacturing Quality for Drugs was arranged prior to the inspection, and a conclusive session including lectures on related topics was held after the inspection to deepen their understanding of the GCTP inspection.
The PMDA continues to provide training opportunities and contributes to the capacity building of the NPRA to improve patient access to medical products in Asia.
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC GCTP Inspection Training for NPRA
Events and Symposia